{
    "Trade/Device Name(s)": [
        "Rightest Blood Glucose Monitoring System GM700",
        "Rightest Blood Glucose Monitoring System GM650",
        "GE200 Blood Glucose Monitoring System",
        "GE300 Talking Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Bionime Corporation",
    "510(k) Number": "K141292",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110737",
        "K120423",
        "K123008"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "April 28, 2015",
    "Summary Letter Received Date": "May 1, 2015",
    "Submission Date": "April 28, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Rightest Blood Glucose Meter GM700",
        "Rightest Blood Glucose Meter GM650",
        "GE200 Blood Glucose Meter",
        "GE300 Talking Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Dehydrogenase electrochemical biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Bionime Corporation Rightest GM700/GM650 and GE200/GE300 blood glucose monitoring systems using dehydrogenase electrochemical biosensor technology",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, or palm for self-testing by individuals with diabetes at home as an aid to monitor the effectiveness of diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}